Scientific activity and scientific production
"Cima's scientific activity has generated publications in journals of high scientific impact, patented biomedical inventions and coordination in international projects."
ANTONIO PINEDA
SCIENTIFIC DIRECTOR. CIMA UNIVERSIDAD DE NAVARRA
2022-2023 in data
301
scientific publications in total
487
professionals work at Cima
244
scientific publications
in the first quartile
56
Collaboration agreements
13,26
average impact factor
with authorship
+600
national and international
media coverage
with authorship
More information
Outstanding scientific publications
Year 2022
|
|
|
Alonso MM et al. New England Journal of Medicine. |
| Pastor F. Molecular Cancer. División de Innovación Tecnológica Primer decil. Top 3 |
|
|
|
Pastor F. Molecular Cancer. |
|
|
| Berraondo P et al. Annals of Oncology. División de Cáncer Primer decil. |
|
|
| Calvo A et al. Nature Medicine División de Cáncer Primer decil. Top 3 |
|
|
| San Miguel J et al. Journal of Clinical Oncology. División de Cáncer Primer decil |
|
|
| Diez J et al. European Heart Journal. División Cardiovascular Primer decil. Top 3 |
| Paiva B et al. Journal of ClinicalOncology. División de Cáncer Primer decil. |
| Lecanda F et al. Cancer Discovery. Colaboración Dr. Vicent División de Cáncer Primer decil |
|
|
| San Miguel J et al. The Lancet Haematology. División de Cáncer Primer decil. Top 3 |
|
|
| Melero I et al. Cancer Discovery División de Cáncer Primer decil. |
| Odero MD et al. Blood. División de Cáncer Primer decil. Top 3 |
| Prósper F et al. Cell Metabolism. División de Cáncer Primer decil. Top 3 |
| Fontanellas A et al. Science Traslational Medicine. División de Cáncer Primer decil. Top 3 |
|
|
| Dubrot J et al. Nature Immunology División de Cáncer Primer decil. |
|
|
| Ortiz de Solórzano C et al. Medical Image Analysis División de Innovación Tecnológica Primer decil. Top 3 |
Scientific activity of the
Cima Universidad de Navarra
Latest scientific publications
- DSTYK Inhibition Sensitizes Non-Small Cell Lung Cancer To Taxane-Based Chemotherapy Nov 11, 2024 | Magazine: Journal of Thoracic Oncology
- Investigation in the cannabigerol derivative VCE-003.2 as a disease-modifying agent in a mouse model of experimental synucleinopathy Nov 1, 2024 | Magazine: Behavioral and Brain Functions
- Safe and successful gut-restricted adsorbent strategy against cirrhosis and acute-on-chronic liver failure Oct 26, 2024 | Magazine: Gut
- Pristine Photopolymerizable Gelatin Hydrogels: A Low-Cost and Easily Modifiable Platform for Biomedical Applications Oct 15, 2024 | Magazine: Antioxidants